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0 Activation of Pak by membrane localization mediated 
by an SH3 domain from the adaptor protein Nck. 
Wange Lu, Steve Katz, Ruchika Gupta and Bruce J Mayer 
(1997). Curr. Biol. 7, 85-94. 
SK homology 2 and 3 (SH2 and SH3) domains are found in a 
wide variety of proteins implicated in signaling and 
frequently mediate protein-protein interactions in signal 
transduction. The adaptor protein Tck consists of three SH3 
domains followed by one SH2 domain. Although Sck is 
presumed to bind to tyrosine-phosphorylated proteins using 
its SH2 domain, 
Stimulated cell: Nck-Pak complex 
at the membrane; Pak is activated 
and to bind to 
downstream 
effector proteins 
nom Activated I 
Rho family that are involved in regulating the organization of 
using its SH3 
the actin cytoskeleton. The authors show that Nck can 
mediate the relocalization and subsequent activation of the 
domain, little is 
Pakl kinase. Nck associates with Pak in vi’do, using the 
second of its three SH3 domains, and the localization of this 
known about its 
individual Nck SH3 domain, or of Pak kinase itself, to the 
membrane results in activation of Pak and stimulation of 
biological function 
downstream mitogen activated protein kinase cascades. 
Activation of downstream signaling by the membrane- 
‘I’he Pak family of 
localized Nck SH3 domain is blocked by a kinase-inactive 
mutant form of Pakl. Thus, localization of Pakl to the 
serine/threonine 
membrane is sufficient for its activation. The results imply 
that the Nck adaptor protein might link changes in tvrosine 
kinases are known 
phosphorylation of cellular proteins to the Cdc42/Pak 
signaling pathway. 
to be activated by 
16 January 1997*, Research Paper, Current Biology 
binding to the 
GTP-bound form 
of Cdc42 or Racl, 
which are small 
CXI’ases of rhe 
1 CD4-independent association between HIV-1 gpl20 
and CXCR4: functional chemokine receptors are 
expressed in human neurons. Joseph Hesselgesser, 
Meredith Halks-Miller, Virginia DelVecchio, Stephen C 
Peiper, James Hoxie, Dennis L Kolson, Dennis Taub and 
Richard Horuk (1997). Curr. Biol. 7, 112-l 21. 
Chemokines are a family of proteins rhat attract and activate 
immune cells by inreracting with specific receptors on the 
surface of their targets. It has been shown that specific 
chemokines can inhibit HI\.-1 infection and thar chemokine 
receptors can function as coreceptors, in combination with 
CD4. for HI\‘-1 invasion. The authors have shown previousI) 
that certain chemokine receptors are expressed on subsets of 
neurons in various regions of the adult central nervous system. 
ITsing a combina- 
tion of immuno- 
histochemical 
staining and 
receptor-binding 
studies. the authors 
show that hNT 
cells (differenciatcd / 
human neurons 
derived from the cell line NTera 2) express the functional 
chemokine receptors CXCRZ, CXCR4, CCRl and CCRS. 
Specific chemokines bind with high affinity to hN’1‘ neurons. 
They also show that the emelope glycoprotein from the ‘I’-cell- 
tropic human immunodeficiency- virus 1 (HI\‘-1) strain IIIB is a 
CD4-independent, dose-dependent inhibitor of the binding of 
srromal cell-derived facror 1 to its receptor, CXCR4. ‘I’hesc data 
support the recent findings that members of the chemokine 
21 January 1997, Research Paper, Current Biology 
receptor family, including CCRS and CX(:R4. function as 
coreceptors in combination with CD4 for HIV-l invasion, and 
provide evidence for the direct, CD4-independent. association 
of the viral envelope protein of the HIV-1 strain IIIR \vith the 
chcmokine receptor CXCR4. 
0 CD22 is a negative regulator of B-cell receptor 
signalling. Lars Nitschke, Rita Carsetti, Bettina Ocker, 
Georges KBhler and Marinus C Lamers (1997). Curr. Biol. 
7, 133-l 43. 
Antibody responses are triggered by binding of antigen to the 
H-cell antigen receptor (RCR). ‘I’he strength of the resulting 
signal determines the outcome of the response, which may 
vary from the induction of tolerance to rhe antigen, to the 
production of specific high-affinity antibodies. Additional 
*Current Biology and Folding & Design are published using a 
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cell-surface proteins, such as the transmembrane protein 
CD22, can assist the BCR in its function. ‘l’he cytoplasmic tail 
of CD22 contains three immunoreceptor tyrosine-based 
inhibitory motifs, which are phosphorylated upon BCR- 
crosslinking and can bind the tyrosine phosphatase SHP-1, a 
putative negative regulator of signaling from the BCR. To 
assess the role of CD22 in ntio, the authors have generated 
C1122-1-mice by targeted gene inactivation. These mice have 
normal numbers of peripheral B cells, but the phenotype of 
these cells is more mature than that seen in the wildtype. 
Recirculating B cells are absent from the bone marrow but the 
distribution of the two B-cell subtypes, B-l and B-Z, is normal. 
After B(:R-cross- 
I ‘. ” _ 
I: 
5 I’ . 
,:.* linking in h-o, 
, 
. .* 2 splenic CD22-“B 
an increased 
proliferative response to the B-cell mitogen lipopolysaccharide 
(1,PS) and a shorter average lifespan in the B-cell compart- 
ment. Furthermore, T-cell independent immune responses are 
impaired, whereas ‘I.-cell dependent responses are normal. 
The authors suggest that the absence of CD22 expression 
lowers the signaling threshold for BCR-cross-linking, changing 
the fate of the R cell. In their model, engagement of the 
receptor without ‘I’-cell help leads to increased induction of 
apoptosis, explaining the shorter lifespan of CI122IB cells and 
the low response to T-cell independent antigens. 
21 January 1997, Research Paper, Current Biology 
Cl Ribosomes and ribosomal RNA as chaperones for 
folding of proteins. Wieslaw Kudlicki, Ashley Coffman, 
Gisela Kramer and Boyd Hardesty (1997). Fold. Des. 
2, 101-108. 
Provocative recent reports indicate that the large subunits of 
either prokaryotic or eukaryotic ribosomes have the capacity to 
promote the refolding of denatured enzymes. In this paper, 
large subunits of salt-washed Eschetichia co/i ribosomes have 
been shown to promote the refolding of denatured rhodanese. 
The ability of the ribosomes to carry out renaturation is a 
property of the SOS 
ribosomal subunit, 
specifically the 23s 
rRNA. The 
refolding and 
release of 
enzymatically 
active rhodanese 
leaves the 
ribosomes in an 
inactive state or conformation for subsequenr rounds of 
refolding. Inactive ribosomes can then be activated b) 
elongation factor G (El--G) plus G’I’P or by cleavage of their 
23s rRNA by a-sarcin. .4ctivation by either mechanism is 
strongly inhibited by the Et;-(XDP,fusidic acid complex. 
4 February 1997, Research Paper, Folding & Design 
0 The structure of an energy-coupling protein from 
bacteria, IIBce”obiose, reveals similarity to eukaryotic 
protein tyrosine phosphatases. Rob LM van Montfort, 
Tjaard Pijning, Kor H Kalk, Jonathan Reizer, Milton H Saier 
Jr, Marjolein MGM Thunnissen, George T Robillard and 
Bauke W Dijkstra (1997). Structure 5, 21 7-225. 
The bacterial phosphoenolpyruvate-dependent phospho- 
transferase system (PTS) mediates the energy-driven uptake 
of carbohydrates and their concomitant phosphorylation; it is 
also intimately involved in the regulation of a v-aricty of 
metabolic and transcriptional processes in the bacterium. ‘I’he 
multiprotein PTS 
consists of 3 
membrane channel 
and at least four 
cytoplasmic 
protcins or protein 
domains that 
s I 0 sequentially 
transfer a 
phosphql group 
from phosphoenol- 
pyruvate to the 
transported 
carbohydrate. ‘I’he 
crystal structure of the IIB enzyme specific for cellobiose, 
IIB’r”“b”‘“” (molecular weight 11.4kDa), has been dctcrmined 
(1 .Si’i resolution; R factor of 18.7%). ‘I-he enzyme consists of a 
single four-stranded parallel @ sheet flanked by 01 heliccs on 
both sides. The phosphorylation site ((:yslO) is located at the 
carboxy-terminal end of the first p strand. No positi\rel) 
charged residues, which could assist in phosphor);1 transfer, can 
be found in or near the active sire. A comparison between 
IIBce”oblo\c and the structurally similar low molecular weight 
protein tyrosine phosphatases provides insight into the 
mechanism of the phosphoryltransfer reactions in which 
IIBce”ob~“sc is involved. The differences in tertiary struclurc 
and active-site composition between IIB”““b’““’ and the 
glucose-specific IIB Y’ucO\c give a structural explanation for why 
the carbohydrate-specific components of different families 
cannot complement each other. 
15 February 1997, Research Article, Structure 
0 Structures of a hemoglobin-based blood substitute: 
insights into the function of allosteric proteins. Kenneth 
S Kroeger and Craig E Kundrot (1997). Structure 5, 
227-237. 
Potential blood substitutes can be based on hemoglobin, but 
two problems arise with acellular hemoglobin-based blood 
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substitutes: the oxygen affinity of purified human hemoglobin 
is too high for it to deliver oxygen to tissues, and hemoglobin 
tetramers dissociate into &3 dimers that can cause kidney 
damage. In this paper, the structure of the blood substitute 
rHbl.1 is described in two forms: the deoxy-rHbl.1 (Z.OA 
resolution) and cyanomet-rHbl.1 (2.hA resolution). Deoxy- 
rHbl.1 adopts the classic ‘7‘ state’ quaternary structure. but 
cyanomet-rHhl.1 adopts a novel quaternary structure, the 1’~ 
state. ‘I’he most striking feature of the tertiary structures is that 
rHbl.l has a reduced oxygen affinity as a result of breaking a 
charged hydrogen bond involving I,ysplO8 in the ‘1’313 state 
transition. In addition, dimerization is prevented by the 
by changing the relative stability of the deoxy and ligand- 
bound states. It also highlights the importance of small 
conformarional changes in allosteric proteins, e\-en in their 
most rigid domains. Three ligand-bound quatcrnar) structures 
of hemoglobin (Ii, Y/R2 and B) have now been described 
whereas only one quaternary snwture has been observed for 
deoxyhemoglobin (T). ‘I’he structural degeneracy of the high 
oxygen affinity form of hemoglobin is an important reminder 
that allosteric proteins may have multiple quaternary- structures 
that are functionally very similar. ‘I’his degeneracy of quater- 
nary structures has important implications for the regulation of 
allosteric proteins, because different quatcrnary structures ma) 
be stabilized by different allosteric effecters. 
15 March 1997, Research Article, Structure 
0 The crystal structure of the flavin containing enzyme 
dihydroorotate dehydrogenase A from Lactococcus 
lactis. Paul Rowland, Finn S Nielsen, Kaj Frank Jensen and 
Sine Larsen. Structure 5, 239-252. 
Dihydroorotate dehydrogenase (DHOD) is a tlavin mono- 
nucleotide containing enzyme which catalyzes the oxidation of 
(A’)-dihydroorotate to orotate. ‘There is currently great interest 
in investigating inhibitors of DHOD as potential therapeutic 
agents for treating diseases in\,olving aberrant cell proliferation. 
DHOD has recently been implicated as a possible target of the 
novel immunosuppressive agent leflunomide, which has shown 
promise in human clinical trials for rheumatoid arthritis and in 
blocking rejection after allograft and xenograft. Brequinar 
sodium is another immunosuppressive agent known to work by 
inhibiting mitochondrial DHOD, and consequenrly the 
production of IYI\IP in ci’r HOOD pyrimidine biosynthesis. DHOD 
from Lactomms /actis contains two genes encoding different 
DHODs: the t\vo enzymes from I,. In&c belong to two of the 
families. whereas the enzyme from I+;. ro/i is a representative of 
rhe third. ‘I’his paper describes rhe first three-dimensional 
structure of a DHOD, the crystal structure of DHODA from 
I,. lnrfir (2.0 I’\ resolurion). ‘I’his structure has allo\ved rhe 
function of many of the conserved residues in DHODs co be 
identified, many of which are associated with binding the 
flavin group. In addition, important differences in some of the 
actir-e-site residues M hich \.ar\ across rhe distinct DHOD 
families, implv significant mechanistic differences. ‘I‘he 
substrate ca\ it>-, although buried, is located beneath a highly 
conserx ed loop which is much less ordered than rhc rest of the 
kprotcin and ma)- be important in giving access to the ca\,ir);. 
The location of the conserved residues surrounding this cavit\- 
suggests the potential orientation of the substrate. 
15 February 1997, Research Article, Structure 
2 A new structural class of serine protease inhibitors 
revealed by the structure of the hirustasin-kallikrein 
complex. Peer RE Mittl, Stefania Di Marco, Gabriele 
Fendrich, Gabriele Pohlig, Jutta Heim, Christian 
Sommerhoff, Hans Fritz, John P Priestle and Markus G 
Griitter (1997). Structure 5, 253-264. 
I-lirustasin is a potent inhibitor of tissue kallikrein and a 
member of a family of serine protease inhibitors. Elevated 
levels of kallikrein have been found in human colon carcinoma 
cell lines and in human breast cancer cells. ‘I-he crystal 
structure of rhe complex between tissue kallikrein and 
hirustasin was analyzed at 2.4A resolution. Hirustasin folds 
dominated by five 
disulfide bridges 
and is sparse in 
secondary 
structural elements. 
‘I’he cysteine 
residues, which are 
conserved in 
I ’ related inhibitors, 
are connected in an ahab C&W% pattern that causes rhe 
polypeptide chain to fold into two similar motifs. The disulfide 
bridges maintain the tertiary structure and present the primary 
binding loop to the active site of the procease. The general 
structural topography and disulfide connectivity of hirustasin 
has not previously been described. The crystal structure of the 
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kallikrein-hirustasin complex reveals that hirustasin differs 
from other serine protease inhibitors in its conformation and its 
disulfide bond connectivity, making it the prototype for a new 
class of inhibitor. The disulfide pattern shows that the 
structure consists of two domains, but only the carboxy- 
terminal domain interacts with the protease. The disulfide 
pattern of the amino-terminal domain is related to the pattern 
found in other proteins. Kallikrein recognizes hirustasin by the 
formation of an antiparallel p sheet between the protease and 
the inhibitor. ‘I‘he I’, arginine binds in a deep negatively 
charged pocket of the enzyme. An additional pocket at the 
periphery- of the active site accommodates the sidechain of 
the P, valine. 
15 February 1997, Research Article, Structure 
domain that contains the active site closely resembles that of 
alkaline phosphatase: the calcium ion in the sulfatasc can be 
superposed on one of the zinc ions in alkaline phosphatase and 
the sulfate ester of Cys91 can bc superposed on the phosphate 
ion found in the active site of alkaline phosphatase. 
15 February 1997, Research Article, Structure 
0 Structure of a human lysosomal sulfatase. Charles S 
Bond, Peter R Clements, Samantha J Ashby, Charles A 
Collyer, Stephen J Harrop, John J Hopwood and J Mitchell 
Guss (1997). Structure 5, 277-289. 
Sulfatases catalyze the hydrolysis of sulfuric acid esters on the 
pathways for the catabolism of glycosaminoglycans and 
glycolipids and in the synthesis of steroid hormones. 
Deficiencies of specific lysosomal sulfatases that are involved 
in the degradation of glycosaminoglycans lead to rare inherited 
clinical disorders termed mucopolysaccharidoses. Studies of 
multiple sulfatase deficiency have contributed to the 
identification of the location and the characterization of the 
sulfatase active site. ‘1’0 understand the catalytic mechanism of 
sulfatases, and ultimately the determinants of their substrate 
specificities, the authors determined the crystal structure of 
amino-acetyl- 
galactosamine-4- 
sulfatase (2.5 K 
resolution) at both 
123K and 273K. 
The structure has 
two domains, the 
larger of which 
belongs to the CL/~ 
class of proteins 
and contains the 
active site. 
Preliminary data is 
presented for 
crystals soaked in 
the monosaccharide 
amino-acetyl- 
galactosamine, the structure of which forms a product complex 
of the enzyme. ‘I’he structure of amino-acetylgalactosamine-4- 
sulfatase reveals that residues conserved amongst the sulfatase 
family are involved in stabilizing the calcium ion and the 
sulfate ester in the active site. This suggests an archetypal fold 
for the family of sulfatases. A catalytic role is proposed for the 
post-translationatly modified highly conserved cysteine 
residue. Despite a lack of any previously detectable sequence 
similarity to any protein of know-n structure, the large sulfatase 
